Today: 3 July 2026
Oracle stock slips after Morgan Stanley warning; TikTok U.S. deal puts ORCL in play
24 January 2026
2 mins read

Oracle stock slips after Morgan Stanley warning; TikTok U.S. deal puts ORCL in play

New York, January 23, 2026, 17:59 EST — After-hours

  • Oracle shares ended the day down 0.6%, slipping further in after-hours trading
  • Morgan Stanley lowered its price target for Oracle, citing increased funding demands driven by AI chip capacity expansion
  • Reuters reported that Oracle is set to acquire a 15% stake in the new U.S. joint venture of TikTok

Oracle shares slipped in after-hours trading Friday following a price target cut from Morgan Stanley. The bank warned Oracle faces “little room for error” as it ramps up GPU-as-a-service — leasing graphics processing units crucial for AI model training and operations. Oracle ended the session down 0.59% at $177.13, slipping further to $176.95 after the bell. Investing.com

The call comes as investors wrestle with how much Oracle might need to spend—and borrow—to support a jump in long-term cloud commitments linked to AI workloads. Back in December, Oracle raised its fiscal 2026 capital expenditure forecast by $15 billion, up from the $35 billion projected in September. Analysts flagged the funding risk as an active concern.

Oracle made headlines again this week as ByteDance announced it had sealed a deal to form a majority American-owned TikTok USDS joint venture, designed to protect U.S. user data and sidestep a potential U.S. ban. According to Reuters, Oracle, Silver Lake, and Abu Dhabi-backed MGX will each own 15% of the venture, with ByteDance holding 19.9%.

Morgan Stanley’s Keith Weiss flagged the GPU rental segment as a potentially “sizable revenue opportunity,” but cautioned the expansion “will push EPS below targets and drive materially higher funding needs.” The bank slashed its price target from $320 to $213 and kept its equal-weight rating. It also noted credit risks might not be fully priced into spreads; CDS, or credit default swaps, are insurance on a borrower’s debt. Investing.com India

Some analysts sounded more optimistic. Guggenheim stuck to its buy rating and maintained a $400 price target. KeyBanc also held an overweight rating, targeting $300, according to a summary on Investing.com.

Oracle insists its pipeline underpins years of growth ahead. In its latest quarterly report, the company revealed remaining performance obligations — revenue contracted but not yet booked — climbed to $523 billion. Finance chief Doug Kehring attributed the boost to fresh deals with Meta, Nvidia, and others.

Traders are zeroing in less on the headline backlog and more on Oracle’s pace of converting AI capacity into revenue. The financing strategy behind the ramp-up will also be under close watch. Additional info on the TikTok venture’s operating setup and timeline could shift the story heading into next week.

The risk scenario is clear. Should demand or prices for rented AI chips weaken, Oracle might face hefty data center expenses and financing charges well before any profits materialize. Plus, TikTok’s U.S. setup has been under political fire for years and could draw fresh scrutiny despite changes in ownership.

Oracle’s fiscal third-quarter report, due March 9, marks the next big catalyst, according to Zacks’ earnings calendar. Investors will watch closely for shifts in capital spending and any updates on funding needs as the company releases its numbers.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Guardant Health (GH) trades near fair value as Shield coverage expands
    July 3, 2026, 2:56 PM EDT. Guardant Health (GH) is up more than 350% in the past three years, lifted by new insurance coverage for its Shield test and FDA clearances for Guardant360 CDx. Even after the run, a DCF analysis puts the stock's value close to where it trades now. GH swaps at 20.6 times sales, well above other Healthcare stocks. Cash burn continues, with a free cash flow loss of $232.5 million, leaving dilution a risk. Some investors weigh the strong revenue drivers against that burn as GH sits at the top end of its valuation range.
Ergo founder John Purdy dies at 63, just after Presidio closes takeover
Previous Story

Ergo founder John Purdy dies at 63, just after Presidio closes takeover

Exxon Mobil stock price rises after-hours as XTO shops $1 billion Eagle Ford assets ahead of Q4 results
Next Story

Exxon Mobil stock price rises after-hours as XTO shops $1 billion Eagle Ford assets ahead of Q4 results

Go toTop